Target intelligence / Profile preview

Extracellular matrix protein 1 pseudogene 2 (ECM1P2)

Target
ECM1P2
Molecular classification
Other (Pseudogene)
01

Overview

Extracellular matrix protein 1 pseudogene 2 (ECM1P2) is a pseudogene that shares sequence similarity with the functional ECM1 gene but is itself non-coding and does not produce a protein[3]. Pseudogenes like ECM1P2 are often formed through gene duplication or retrotransposition but acquire mutations such as premature stop codons, frameshifts, or truncations that prevent them from encoding functional proteins[5]. Although historically considered "junk DNA," there is increasing evidence that some pseudogenes can play regulatory roles in gene expression—primarily through mechanisms such as acting as competing endogenous RNAs (ceRNAs) that "sponge" microRNAs shared with their functional paralogs, thus indirectly modulating expression of other genes[1][5]. However, there is no published evidence or characterization specifically for ECM1P2 in terms of biological function, disease involvement, or relevance as a therapeutic target or biomarker. ECM1P2 should not be confused with ECM1, the functional extracellular matrix protein 1, which does participate in cell signaling, cancer, and tissue remodeling[4]. By all available peer-reviewed and bioinformatics sources, ECM1P2 is considered a pseudogene and is not a receptor, transporter, enzyme, or direct drug target.

Other names
ECM1P2
02

Biological functions

Potential to act as a competitive endogenous RNA (ceRNA) or microRNA decoy (only speculative)
03

Disease associations

Other (no evidence for direct role)

Beyond the preview

Go deeper on Extracellular matrix protein 1 pseudogene 2 (ECM1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extracellular matrix protein 1 pseudogene 2 (ECM1P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call